When a clinical drug is created, the supertypes below must either already exist or must be created. Guidance on their creation exists in the following pages.
- Medicinal Product Form containing only
- Medicinal Product Form containing
- Medicinal Product containing only
- Medicinal Product containing
For example,
1172863005 Paracetamol 1 g oral tablet has the following supertypes:
These concepts in the International Release, their descriptions and their | Has active ingredient (attribute)| value, represent the base ingredient, not a modification.
For example,
1204319004 |Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug)| has medicinal product and medicinal product form supertypes with retinol, not retinol palmitate. Retinol palmitate is a modification of Retinol and thus should not be used in the creation of the medicinal product and medicinal product form supertypes.
Exceptions to use a modified substance are explicitly identified below:
| Exceptions | Examples |
| Benzylpenicillin | 1234765004 |Product containing only benzathine benzylpenicillin in parenteral dose form (medicinal product form)| 323404007 |Product containing benzathine benzylpenicillin (medicinal product)| |
Chemical element with multiple modification | 422232005 |Calcium lactate gluconate (substance)| 715220007 |Tenofovir alafenamide (substance)| |
Chloral hydrate | 778711000 |Product containing only chloral hydrate in oral dose form (medicinal product form)| 386735001 |Product containing chloral hydrate in oral dose form (medicinal product form)| 775158004 |Product containing only chloral hydrate (medicinal product)| |
Liposome or lipid complex substances | 426490000 |Vincristine liposome (substance)| 425953004 |Amphotericin B lipid complex (substance)| 768664009 |Amphotericin B phospholipid complex (substance)| 427544000 |Amphotericin B cholesteryl sulfate complex (substance)| |
Pegylated substance | 385544005 |Pegfilgrastim (substance)| 770965008 |Pegvaliase (substance)| |
Radiopharmaceutical | 783865003 |Product containing only cyanocobalamin (58-Co) (medicinal product)| 783867006 |Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form)| 783856005 |Product containing sodium iodide (131-I) in parenteral dose form (medicinal product form)| 783854008 |Product containing sodium iodide (131-I) (medicinal product)| |
Silver sulfadiazine | 864009007 |Product containing only silver sulfadiazine in cutaneous dose form (medicinal product form)| 771756000 |Product containing silver sulfadiazine in cutaneous dose form (medicinal product form)| |
Feedback
Overview
Content Tools
Apps